Truvestments Capital’s Editas Medicine EDIT Stock Holding History

Truvestments Capital’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$198	Hold	61	–	–	﹤0.01%	1100
2026 Q1	$151	Hold	61	–	–	﹤0.01%	1123
2025 Q4	$125	Hold	61	–	–	﹤0.01%	989
2025 Q3	$212	Hold	61	–	–	﹤0.01%	992
2025 Q2	$134	Hold	61	–	–	﹤0.01%	930
2025 Q1	$71	Hold	61	–	–	﹤0.01%	1006
2024 Q4	$77	Hold	61	–	–	﹤0.01%	991
2024 Q3	$208	Buy	+61	New	+$266	﹤0.01%	900
2024 Q2	–	Sell	-61	Closed	-$453	–	369
2024 Q1	$453	Hold	61	–	–	﹤0.01%	677
2023 Q4	$618	Hold	61	–	–	﹤0.01%	733
2023 Q3	$476	Hold	61	–	–	﹤0.01%	650
2023 Q2	$502	Hold	61	–	–	﹤0.01%	655
2023 Q1	$442	Sell	61 -37	-38%	-$329	﹤0.01%	634
2022 Q4	$869	Hold	98	–	–	﹤0.01%	836
2022 Q3	$1K	Hold	98	–	–	﹤0.01%	587
2022 Q2	$1K	Buy	+98	New	+$1.31K	﹤0.01%	599
2022 Q1	–	Sell	-98	Closed	-$3K	–	286
2021 Q4	$3K	Hold	98	–	–	﹤0.01%	525
2021 Q3	$4K	Hold	98	–	–	﹤0.01%	468
2021 Q2	$6K	Hold	98	–	–	﹤0.01%	436
2021 Q1	$4K	Sell	98 -31	-24%	-$1.77K	﹤0.01%	538
2020 Q4	$9K	Buy	+129	New	+$5.3K	0.01%	440
2020 Q3	–	Sell	-129	Closed	-$3K	–	389
2020 Q2	$3K	Buy	+129	New	+$3.37K	﹤0.01%	485
2019 Q4	–	Sell	-223	Closed	-$5K	–	273
2019 Q3	$5K	Sell	223 -24	-10%	-$594	﹤0.01%	570
2019 Q2	$6K	Hold	247	–	–	﹤0.01%	592
2019 Q1	$6K	Buy	+247	New	+$5.59K	﹤0.01%	575
2018 Q3	$8K	Buy	+251	New	+$8.11K	﹤0.01%	677

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Truvestments Capital's EDIT Position: Q2 2026 in Review

Truvestments Capital held its Editas Medicine (EDIT) position steady in Q2 2026 at 61 shares worth $198. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

Truvestments Capital first reported a position in EDIT in Q3 2018 and has held it in 26 quarters since. The position peaked at $9K in Q4 2020. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Truvestments Capital held 61 shares of Editas Medicine worth $198 as of Q2 2026.
Truvestments Capital left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #1100 holding.
Truvestments Capital first reported a position in Editas Medicine in Q3 2018 and has held it in 26 quarters since.
Truvestments Capital's Editas Medicine position peaked at $9K in Q4 2020.
215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.